PEBP1 and Miyoshi myopathy: Baritaki S. et al. initially reported, in MM tissue compared to normal bone marrow cells, a direct correlation between higher expression of RKIP and YY1, a transcription factor implicated in the modulation of tumour cell chemo/immuno-resistance [66].